English
Lupin Q2 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
2,054.50
-16.85 (-0.81%)
-16.85 (-0.81%)Volume17.14 K
Updated: Tue 9 Dec, 2025 | 14:28:52
NSE
2,061.70-9.00 (-0.43%)
-9.00 (-0.43%)Volume5.38 L
Updated: Tue 9 Dec, 2025 | 14:14:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹7,047.51 Cr.(24.23%)
- Operating Profit₹1,820.83 Cr.(73.19%)
- Profit After Tax₹1,477.92 Cr.(73.35%)
- Operating Margin25.84%(39.40%)
Note: Comparison is on YoY basis
Quarterly - Lupin Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,226.68 | 4,925.95 | 6.11% | 4,621.37 | 13.10% |
| Depreciation/ Amortization | 316.77 | 298.98 | 5.95% | 256.92 | 23.30% |
| Operating Income | 1,820.83 | 1,342.39 | 35.64% | 1,051.36 | 73.19% |
| Net Income | 1,477.92 | 1,219.03 | 21.24% | 852.58 | 73.35% |
| Other Operating Expenses Total | 1,979.58 | 1,772.04 | 11.71% | 1,666.99 | 18.75% |
| Net Income Before Taxes | 2,006.97 | 1,415.54 | 41.78% | 1,054.86 | 90.26% |
| Total Revenue | 7,047.51 | 6,268.34 | 12.43% | 5,672.73 | 24.23% |
| Selling/ General/ Admin Expenses Total | 1,105.56 | 1,083.00 | 2.08% | 1,007.52 | 9.73% |
| Diluted Normalized EPS | 32.28 | 26.62 | 21.26% | 18.64 | 73.20% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.